Table 2.
Distribution of markers, age, gender and stage by WHO type
| Markers | Freq (%) (n = 66) | A & AB (n = 24) | B1 & B2 (n = 13) | B3 (n = 17) | Thymic carcinoma (n = 12) | |
|---|---|---|---|---|---|---|
| Age | 62.5 (23–90) | 65 (23–79) | 62 (39–90) | 63 (34–80) | 59 (28–81) | |
| Gender | Male | 31 (47) | 10 (41.7) | 8 (61.5) | 10 (58.8) | 3 (25) |
| Female | 35 (53) | 14 (58.3) | 5 (38.5) | 7 (41.2) | 9 (75) | |
| Stage | I | 31 (47) | 17 (70.8) | 9 (69.2) | 5 (29.4) | 0 (0) |
| II | 18 (27.3) | 6 (25) | 2 (15.4) | 7 (41.2) | 3 (25) | |
| III | 8 (12.1) | 0 (0) | 2 (15.4) | 5 (29.4) | 1 (8.3) | |
| IV | 9 (13.6) | 1 (4.2) | 0 (0) | 0 (0) | 8 (66.7) | |